Study of two different drug effect in spinal anesthesia

Phase 4

Not yet recruiting

Conditions: Encounter for other specified special examinations, (2) ICD-10 Condition: M972||Periprosthetic fracture around internal prosthetic ankle joint, (3) ICD-10 Condition: M970||Periprosthetic fracture around internal prosthetic hip joint, (4) ICD-10 Condition: M971||Periprosthetic fracture around internal prosthetic knee joint,

Registration Number: CTRI/2021/09/036980

Lead Sponsor: Mahatma gandhi medical college and hospital

Brief Summary: we compare effect of fentanyl and nalbuphine as adjuvant to bupivacaine in spinal anaesthesia in lower limb orthopedic surgeries. we compare onset of sensory block , maximum dermatomal block height, onset of complete motor block.

we also compare time of first rescue analgesia , patient satisfaction.

Detailed Description: Not available

Recruitment & Eligibility

Status: Not Yet Recruiting

Sex: All

Target Recruitment: 80

Inclusion Criteria

Patients withASAclass1/2 lower limb surgeries patient giving written and informed consent.

Exclusion Criteria

Patient refusal patient with bledding diasthesis,allergic to study drug,neurological disease, spinal deformity, septicemia Patient with local infection at injection site.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1)The characteristic of sensory and motor block	1)watch for need of post-operative analgesia up to 24 hours \| 2)Watch for regression of sensory block up to T10 for 135 min \| 2)
2)Comparision of hemodynamic parameter and sedation score	1)watch for need of post-operative analgesia up to 24 hours \| 2)Watch for regression of sensory block up to T10 for 135 min \| 2)

Secondary Outcome Measures

Name	Time	Method
1)Time of first rescue analgesia	2) Patient satisfaction and adverse effect

Trial Locations

Locations (1): mahatma gandhi medical college and hospital
🇮🇳
Jaipur, RAJASTHAN, India
mahatma gandhi medical college and hospital
🇮🇳Jaipur, RAJASTHAN, India
dr Khushbu parekh
Principal investigator
9428433390
khushbuparekh770@gmail.com